Social Media Press Releases
RSSShowing Press Releases with Tag: monoclonal antibody
12/10/2007
Micromet and MedImmune Present New Clinical Data for MT103 at the American Society of Hematology Annual Meeting Suggesting Potent Single-Agent Activity in Patients with Relapsed Mantle Cell and Follicular Lymphoma
» read more11/29/2007
Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE® Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin’s Lymphoma Patients
» read more11/26/2007
MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
» read more11/08/2007
MedImmune Presents Data from Its Advancing Inflammatory Disease Portfolio at 71st Annual Meeting of The American College of Rheumatology
» read more10/29/2007
AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
» read more10/29/2007
MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
» read more10/26/2007
MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
» read more10/09/2007
Data from MedImmune Infectious Disease Clinical Programs Presented at European Society for Paediatric Research Annual Meeting
» read more10/04/2007
MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
» read more8/23/2007
MedImmune’s Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
» read more7/23/2007
MedImmune Announces Interim Phase 1 Study Results for Potential Asthma Therapy
» read more6/29/2007
New Study in Journal of Pediatrics Suggests Synagis(R) (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
» read more5/24/2007
